Overall rank by patents
#35,456
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF).
The verdict
Glanbia holds 7 US patents across 13 technology areas, rank #35,456 of 50,000 tracked assignees.
Glanbia Nutritionals(ireland) Ltd. has been granted 7 US utility patents between 2015 and 2019, placing Glanbia Nutritionals(ireland) Ltd. at rank #35,456 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A23L (FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF). As a Foreign Corporation, Glanbia Nutritionals(ireland) Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Glanbia sits between Giletta S.p.a. (7 patents, rank #35,452) and Globachem Nv (7 patents, rank #35,460) - the closest US assignees by grant volume. The composite Innovation Score of 28.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 7 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Glanbia Nutritionals(ireland) Ltd.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Glanbia Nutritionals(ireland) Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GILETTA S.P.A.
7 patents
GKN Aerospace Transparency Systems, Inc.
7 patents
GL & V Luxembourg Sàrl
7 patents
GLADIUS PHARMACEUTICALS CORPORATION
7 patents
GLEASON METROLOGY SYSTEMS CORPORATION
7 patents
GLENN LANE FAMILY LIMITED LIABILITY LIMITED PARTNERSHIP
7 patents
GLICO NUTRITION CO., LTD.
7 patents
GLOBACHEM NV
7 patents
GLANBIA NUTRITIONALS(IRELAND) LTD.
7 patents
What this shows Glanbia holds 7 patents at rank #35,456, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,456 in granted patent volume.
Other assignees with the most granted patents in Glanbia's primary technology class.
Glanbia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2016 | 2 | 28.6% |
| 2017 | 1 | 14.3% |
| 2019 | 2 | 28.6% |
Top 13 of 13 technology areas
Overall rank by patents
#35,456
Across all tracked assignees
28.7 out of 100
How to use this portfolio
Glanbia's 7 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.